Synthesis, Antibacterial, and Antifungal Evaluation of Some New Quinazolinone-Azole Hybrids

References

• D. E. Bloom, and D. Cadarette, “Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response,” Frontiers in Immunology 10 (2019): 549. doi:10.3389/fimmu.2019.00549
   PubMed Web of Science ®Google Scholar
• S. C. Park, Y. M. Kim, J. K. Lee, N. H. Kim, E. J. Kim, H. Heo, M. Y. Lee, J. R. Lee, and M. K. Jang, “Targeting and Synergistic Action of an Antifungal Peptide in an Antibiotic Drug-Delivery System,” Journal of Controlled Release: Official Journal of the Controlled Release Society 256 (2017): 46–55. doi:10.1016/j.jconrel.2017.04.023
   PubMed Web of Science ®Google Scholar
• I. Khan, S. Zaib, S. Batool, N. Abbas, Z. Ashraf, J. Iqbal, and A. Saeed, “Quinazolines and Quinazolinones as Ubiquitous Structural Fragments in Medicinal Chemistry: An Update on the Development of Synthetic Methods and Pharmacological Diversification,” Bioorganic & Medicinal Chemistry 24, no. 11 (2016): 2361–81. doi:10.1016/j.bmc.2016.03.031
   PubMed Web of Science ®Google Scholar
• F. Plescia, B. Maggio, G. Daidone, and D. Raffa, “4-(3H)-Quinazolinones N-3 Substituted with a Five Membered Heterocycle: A Promising Scaffold towards Bioactive Molecules,” European Journal of Medicinal Chemistry 213 (2021): 113070. doi:10.1016/j.ejmech.2020.113070
   PubMed Web of Science ®Google Scholar
• S. Gatadi, T. V. Lakshmi, and S. Nanduri, “4 (3H)-Quinazolinone Derivatives: Promising Antibacterial Drug Leads,” European Journal of Medicinal Chemistry 170 (2019): 157–72. doi:10.1016/j.ejmech.2019.03.018
   PubMed Web of Science ®Google Scholar
• Z. Li, L. Zhao, Y. Bian, Y. Li, J. Qu, and F. Song, “The Antibacterial Activity of Quinazoline and Quinazolinone Hybrids,” Current Topics in Medicinal Chemistry 22, no. 12 (2022): 1035–44. doi:10.2174/1568026622666220307144015
   PubMed Web of Science ®Google Scholar
• J. Zhang, J. Liu, Y. Ma, D. Ren, P. Cheng, J. Zhao, F. Zhang, and Y. Yao, “One-Pot Synthesis and Antifungal Activity against Plant Pathogens of Quinazolinone Derivatives Containing an Amide Moiety,” Bioorganic & Medicinal Chemistry Letters 26, no. 9 (2016): 2273–7. doi:10.1016/j.bmcl.2016.03.052
   PubMed Web of Science ®Google Scholar
• M. A. El-Hashash, M. M. Elshahawi, E. A. Ragab, and S. Nagdy, “Synthesis and Antifungal Activity of Novel Quinazolin-4 (3 H)-One Derivatives,” Synthetic Communications 45, no. 19 (2015): 2240–50. doi:10.1080/00397911.2015.1074697
   Web of Science ®Google Scholar
• S. Y. Abbas, K. A. El-Bayouki, W. M. Basyouni, and E. A. Mostafa, “New Series of 4 (3 H)-Quinazolinone Derivatives: Syntheses and Evaluation of Antitumor and Antiviral Activities,” Medicinal Chemistry Research 27, no. 2 (2018): 571–82. doi:10.1007/s00044-017-2083-7
   Web of Science ®Google Scholar
• D. G. Piotrowska, G. Andrei, D. Schols, R. Snoeck, and M. Grabkowska-Drużyc, “New Isoxazolidine-Conjugates of Quinazolinones—Synthesis, Antiviral and Cytostatic Activity,” Molecules 21, no. 7 (2016): 959. doi:10.3390/molecules21070959
   PubMed Web of Science ®Google Scholar
• M. A. E. A. M. El-Hashash, M. S. Salem, and S. A. M. Al-Mabrook, “Synthesis and Anticancer Activity of Novel Quinazolinone and Benzamide Derivatives,” Research on Chemical Intermediates 44, no. 4 (2018): 2545–59. doi:10.1007/s11164-017-3245-4
   Web of Science ®Google Scholar
• L. A. Kawale, L. Sonali, S. Yadav, and K. Ahire, “Design, Synthesis& Evaluation of Anthihypertensive Activity of 2-{4-(Subsituted Aril) Piperazine-1-yl}-3-(4-Hydroxy Phenyl) Quinazoline-(3H)-One Derivative,” World Journal of Pharmaceutical Research 9 (2016): 1188–95.
   Google Scholar
• N. A. Noureldin, H. Kothayer, E. S. M. Lashine, M. M. Baraka, W. El‐Eraky, and S. A. E. Awdan, “Synthesis, Anticonvulsant Activity, and SAR Study of Novel 4‐Quinazolinone Derivatives,” Archiv Der Pharmazie 350, no. 2 (2017): 1600332. doi:10.1002/ardp.201600332
   Web of Science ®Google Scholar
• A. M. Alaa, L. A. Abou-Zeid, K. E. H. ElTahir, M. A. Mohamed, M. A. A. El-Enin, and A. S. El-Azab, “Design, Synthesis of 2, 3-Disubstitued 4 (3H)-Quinazolinone Derivatives as anti-Inflammatory and Analgesic Agents: COX-1/2 Inhibitory Activities and Molecular Docking Studies,” Bioorganic & Medicinal Chemistry 24, no. 16 (2016): 3818–28.
   PubMed Web of Science ®Google Scholar
• A. Hameed, M. Al-Rashida, M. Uroos, S. A. Ali, M. Ishtiaq, and K. M. Khan, Arshia , “Quinazoline and Quinazolinone as Important Medicinal Scaffolds: A Comparative Patent Review (2011–2016),” Expert Opinion on Therapeutic Patents 28, no. 4 (2018): 281–97. doi:10.1080/13543776.2018.1432596
   PubMed Web of Science ®Google Scholar
• N. Desai, N. Shihory, A. Khasiya, U. Pandit, and V. Khedkar, “Quinazoline Clubbed Thiazole and 1, 3, 4-Oxadiazole Heterocycles: Synthesis, Characterization, Antibacterial Evaluation, and Molecular Docking Studies,” Phosphorus, Sulfur, and Silicon and the Related Elements 196, no. 6 (2021): 569–77. doi:10.1080/10426507.2021.1871732
   Web of Science ®Google Scholar
• D. Pan, H. Du, X. Lü, and X. Bao, “Synthesis and Antibacterial Activities of Novel Quinazoline-2, 4-Dione Derivatives Containing the 1, 2, 4-Triazole Schiff-Base Unit,” Chinese Journal of Organic Chemistry 36, no. 4 (2016): 818. doi:10.6023/cjoc201510005
   Web of Science ®Google Scholar
• X. Wang, J. Chai, X. Kong, F. Jin, M. Chen, C. Yang, and W. Xue, “Expedient Discovery for Novel Antifungal Leads: 1, 3, 4-Oxadiazole Derivatives Bearing a Quinazolin-4 (3H)-One Fragment,” Bioorganic & Medicinal Chemistry 45 (2021): 116330. doi:10.1016/j.bmc.2021.116330
   PubMed Web of Science ®Google Scholar
• Z. Kazeminejad, M. Marzi, A. Shiroudi, S. A. Kouhpayeh, M. Farjam, and E. Zarenezhad, “Novel 1, 2, 4-Triazoles as Antifungal Agents,” BioMed Research International 2022 (2022): 4584846. doi:10.1155/2022/4584846
   PubMed Web of Science ®Google Scholar
• S. Nayak, S. L. Gaonkar, E. A. Musad, and A. M. A. Dawsar, “1, 3, 4-Oxadiazole-Containing Hybrids as Potential Anticancer Agents: Recent Developments, Mechanism of Action and Structure-Activity Relationships,” Journal of Saudi Chemical Society 25, no. 8 (2021): 101284. doi:10.1016/j.jscs.2021.101284
   Web of Science ®Google Scholar
• A. Y. Hassan, M. T. Sarg, A. H. Bayoumi, and M. A. El-Deeb, “Synthesis and Anticancer Evaluation of Some Novel 5-Amino [1, 2, 4] Triazole Derivatives,” Journal of Heterocyclic Chemistry 55, no. 6 (2018): 1450–78. doi:10.1002/jhet.3184
   Web of Science ®Google Scholar
• A. J. A. Y. Kumar, A. N. J. A. L. I. Gupta, V. A. R. S. H. A. Kashaw, G. U. N. J. A. N. Shukla, V. I. K. A. S. Mishra, and S. K. Kashaw, “Syntheses and Anticancer Evaluation of Some Novel 3-[5-(4-Substituted) Phenyl-1, 3, 4-Oxadiazole-2yl]-2-Phenylquinazoline-4 (3H)-Ones,” International Journal of Pharmacy and Pharmaceutical Sciences. 4, no. 1 (2012): 502–6.
   Google Scholar
• C. Sowjanya, V. RamaBharathi, G. K. Devi, and G. Rajitha, “Synthesis and Evaluation of Some Novel 3-[5-Phenyl-1, 3, 4-Oxadiazole-2-yl]-2-(Substituted Styryl)-Quinazoline-4 (3H)-Ones for Antibacterial Activity,” Journal of Chemical and Pharmaceutical Research 3, no. 6 (2011): 212–6.
   Google Scholar
• S. Rajasekaran, and G. Rao, “Synthesis, Antibacterial and Antioxidant Activity of Some 2, 3-Susbtituted Quinazolin-4 (3H)-Ones,” Der Pharmacia Lettre 4, no. 1 (2012): 349–53.
   Google Scholar
• F. Hassanzadeh, H. Sadeghi-Aliabadi, E. Jafari, A. Sharifzadeh, and N. Dana, “Synthesis and Cytotoxic Evaluation of Some Quinazolinone-5-(4-Chlorophenyl) 1, 3, 4-Oxadiazole Conjugates,” Research in Pharmaceutical Sciences 14, no. 5 (2019): 408.
   PubMed Web of Science ®Google Scholar
• X. Wang, H. Hu, X. Zhao, M. Chen, T. Zhang, C. Geng, Y. Mei, A. Lu, and C. Yang, “Novel Quinazolin-4 (3H)-One Derivatives Containing a 1, 3, 4-Oxadiazole Thioether Moiety as Potential Bactericides and Fungicides: Design, Synthesis, Characterization and 3D-QSAR Analysis,” Journal of Saudi Chemical Society 23, no. 8 (2019): 1144–56. doi:10.1016/j.jscs.2019.07.006
   Web of Science ®Google Scholar
• F. Hassanzadeh, H. Sadeghi-Aliabadi, S. Nikooei, E. Jafari, and G. Vaseghi, “Synthesis and Cytotoxic Evaluation of Some Derivatives of Triazole-Quinazolinone Hybrids,” Research in Pharmaceutical Sciences 14, no. 2 (2019): 130. doi:10.4103/1735-5362.253360
   PubMed Web of Science ®Google Scholar
• Z. Arasteh-Fard, K. Akbari Dilmaghani, M. Saeedi, M. Mahdavi, and A. Shafiee, “Synthesis of Novel Phthalazino[1,2-b] Quinazolinedione Derivatives: Efficient and Practical Reaction of 2-Amino-N-Arylbenzohydrazides and 2-Formylbenzoic Acids,” Helvetica Chimica Acta 99, no. 7 (2016): 539–42. doi:10.1002/hlca.201600025
   Web of Science ®Google Scholar
• Z. Arasteh Fard, K. A. Dilmaghani, M. Soheilizad, B. Larijani, and M. Mahdavi, “Synthesis of 5-Arylindazolo [3,2]-b Quinazolin-7(5H)-Ones from 2-Nitrobenzaldehydes,” Tetrahedron 74, no. 18 (2018): 2197–201. doi:10.1016/j.tet.2018.03.018
   Web of Science ®Google Scholar
• M. Ziaie, K. Akbari Dilmaghani, and A. Tukmechi, “Synthesis and Biological Evaluation of 1,2,4-Triazoles and 1,3,4-Oxadiazoles Derivatives Linked to 1,4-Dihydropyridines Scaffold,” Acta Chimica Slovenica 64, no. 4 (2017): 895–901. doi:10.17344/acsi.2017.3506
   PubMed Web of Science ®Google Scholar
• C. E. Schroeder, T. Yao, J. Sotsky, R. A. Smith, S. Roy, Y. K. Chu, H. Guo, N. A. Tower, J. W. Noah, S. McKellip, et al, “Development of (E)-2-((1, 4-Dimethylpiperazin-2-Ylidene) Amino)-5-nitro-N-Phenylbenzamide, ML336: Novel 2-Amidinophenylbenzamides as Potent Inhibitors of Venezuelan Equine Encephalitis Virus,” Journal of Medicinal Chemistry 57, no. 20 (2014): 8608–21. doi:10.1021/jm501203v
   PubMed Web of Science ®Google Scholar
• A. Othman, M. Kihel, and S. Amara, “1,3,4-Oxadiazole, 1,3,4-Thiadiazole and 1,2,4-Triazole Derivatives as Potential Antibacterial Agents,” Arabian Journal of Chemistry 12, no. 7 (2019): 1660–75. doi:10.1016/j.arabjc.2014.09.003
   Web of Science ®Google Scholar
• A. A. Aly, A. Hassan, M. M. Makhlouf, and S. Brase, “Chemistry and Biological Activities of 1,2,4-Triazolethiones-Antiviral and anti-Infective Drugs,” Molecules 25, no. 13 (2020): 3036. doi:10.3390/molecules25133036
   PubMed Web of Science ®Google Scholar
• L. Y. Zhang, B. L. Wang, Y. Z. Zhan, Y. Zhang, X. Zhang, and Z. M. Li, “Synthesis and Biological Activities of Some Fluorine-and Piperazine-Containing 1, 2, 4-Triazole Thione Derivatives,” Chinese Chemical Letters 27, no. 1 (2016): 163–7. doi:10.1016/j.cclet.2015.09.015
   Web of Science ®Google Scholar
• B. L. Wang, Y. Z. Zhan, L. Y. Zhang, Y. Zhang, X. Zhang, and Z. M. Li, “Synthesis and Fungicidal Activities of Novel 1, 2, 4-Triazole Thione Derivatives Containing 1, 2, 3-Triazole and Substituted Piperazine Moieties,” Phosphorus, Sulfur, and Silicon and the Related Elements 191, no. 1 (2016): 1–7. doi:10.1080/10426507.2015.1085040
   Web of Science ®Google Scholar
• M. Benlyas, C. Alem, and Y. Filali-Zegzouti, “Evaluation of Antioxidant, Antibacterial and Antifungal Activities of Eleven Monofloral Honey Samples Collected from Morocco,” Journal of Chemical and Pharmaceutical Research 8, no. 3 (2016): 299–306.
   Google Scholar
• W. M. N. H. W. Salleh, F. Ahmad, K. H. Yen, and R. M. Zulkifli, “Chemical Composition and Biological Activities of Essential Oil of Beilschmiedia Pulverulenta,” Pharmaceutical Biology 54, no. 2 (2016): 322–30. doi:10.3109/13880209.2015.1037003
   PubMed Web of Science ®Google Scholar